Pathophysiology attributable to decline in ARSB extends beyond MPS VI and is associated with other human diseases, including multiple sulfatase deficiency, cystic fibrosis, malignancies and neurologic, cardiac, and respiratory disorders, as presented in Section 14. The gene discussed is ARSB; the disease is mucosulfatidosis.